Table 2.
Demographics and biometric data of the patients at baseline.
| Parameters | Mean ± SD/n (%) | P value | ||
|---|---|---|---|---|
| All patients (n = 93) | Group A (38) | Group B (55) | ||
| Age (years) | 9.95 ± 1.75 | 10.66 ± 1.74 | 9.46 ± 1.60 | 0.004 |
| Sex, male (n/%) | 40 (43.01) | 17 (44.74) | 23 (41.82) | 0.947 |
| PD (mm) | 3.43 ± 0.63 | 3.60 ± 0.73 | 3.31 ± 0.52 | 0.091 |
| AL (mm) | 24.75 ± 0.87 | 25.16 ± 0.89 | 24.46 ± 0.72 | 0.000 |
| SE (D) | − 3.15 ± 1.60 | − 4.32 ± 1.62 | − 2.35 ± 0.99 | 0.000 |
| Total aberrations (µm) | 1.612 ± 0.457 | 1.736 ± 0.484 | 1.526 ± 0.422 | 0.094 |
| HOAs (µm) | 0.400 ± 0.185 | 0.394 ± 0.101 | 0.403 ± 0.190 | 0.965 |
| Horizontal coma (µm) | 0.024 ± 0.251 | − 0.046 ± 0.187 | 0.073 ± 0.278 | 0.076 |
| Vertical coma (µm) | − 0.055 ± 0.242 | − 0.084 ± 0.315 | 0.034 ± 0.177 | 0.624 |
| Spherical aberration (µm) | 0.196 ± 0.082 | 0.218 ± 0.068 | 0.180 ± 0.087 | 0.087 |
AL axial length, PD pupil diameter, SE spherical equivalent, HOAs higher-order aberrations.